DNTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dianthus Therapeutics Inc

Watchlist Manager

Watchlist

Price: 70.93 USD -4.83%

Market Cap: $3.9B

	Dianthus Therapeutics Inc NASDAQ:DNTH	US
	AnorTech Inc F:HR50	CA
	Sino Harbour Holdings Group Ltd HKEX:1663	CN
M	MPC Container Ships ASA OTC:MPZZF	NO

Profitability Summary

Dianthus Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-11 441%

Negative 3Y Average Operating Margin

-4 636%

Declining Operating Margin

-2 403% > -11 441%

Negative Net Margin

-10 097%

Negative 3Y Average Net Margin

-4 125%

Declining Net Margin

-2 243% > -10 097%

Negative Free Cash Flow Margin

-8 178%

Negative 3Y Average Free Cash Flow Margin

-3 279%

Declining Free Cash Flow Margin

-1 764% > -8 178%

Negative ROE

-26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-533%

ROIC is Increasing

-331% > -114%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.